Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
2.
Clin Res Cardiol ; 105(7): 571-4, 2016 Jul.
Article in English | MEDLINE | ID: mdl-26745956

ABSTRACT

Oversensing of physiologic and non-physiologic electrical signals is a relevant cause of malfunctions in subjects with CIED. Physicians taking care of CIED patients must be aware of the potential causes of oversensing and their pattern in EGMs. The present case describes an uncommon source and unique underlying root cause for oversensing in a modern dual-chamber MV rate-adaptive pacemaker.


Subject(s)
Cardiac Pacing, Artificial , Equipment Failure , Pacemaker, Artificial , Sick Sinus Syndrome/therapy , Aged , Cardiography, Impedance , Electrophysiologic Techniques, Cardiac , Equipment Design , Humans , Male , Predictive Value of Tests , Sick Sinus Syndrome/diagnosis , Sick Sinus Syndrome/physiopathology , Signal Processing, Computer-Assisted , Treatment Outcome
3.
J Interv Card Electrophysiol ; 41(1): 75-82, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24943245

ABSTRACT

PURPOSE: In ablation of atrial fibrillation, the single-ring method aims for isolation of the posterior wall of the left atrium (LA) including the pulmonary veins (PVs) but avoiding posterior LA lesions. The aim of this randomized prospective study was to evaluate safety and efficacy of remote magnetic navigation (RMN)-guided single-ring ablation strategy as compared to standard RMN-guided circumferential PV ablation (PVA). METHODS: Eighty consecutive patients undergoing PVA were enrolled prospectively and randomized equally into two study groups. RMN using the Stereotaxis system and open-irrigated 3.5-mm ablation catheters were used with a 3D mapping system in all procedures. Forty patients underwent RMN-guided single-ring ablation, and 40 patients received RMN-guided circumferential PVA. RESULTS: In the circumferential group, 3.3 ± 1.1 PVs were successfully isolated at the end of the procedure as compared to 3.1 ± 1.3 in the single-ring (box) group (p=0.38). All patients in the box group required additional posterior lesions in order to achieve electrical isolation of the PVs. Single-ring ablation was associated with longer procedure duration (p=0.01) and ablation time (p=0.001). After a single procedure, the proportion of patients free of any atrial tachycardia (AT)/atrial fibrillation (AF) episode at 12-month follow-up was 57 % in the box group and 58 % in the circ group. Using RMN, only minor complications have been observed. CONCLUSIONS: RMN-guided single-ring PVA provides comparable acute and long-term success rates as compared to RMN-guided circumferential PVA but requires additional posterior lesions to achieve PV isolation and increased procedure and ablation time. Procedural complication rates are low when using RMN.


Subject(s)
Atrial Fibrillation/surgery , Catheter Ablation/methods , Magnetics/instrumentation , Pulmonary Veins/surgery , Aged , Electrophysiologic Techniques, Cardiac , Female , Humans , Male , Middle Aged , Prospective Studies , Treatment Outcome
4.
J Interv Card Electrophysiol ; 41(1): 65-73, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24893795

ABSTRACT

PURPOSE: Remote magnetic navigation (RMN) is utilized for catheter guidance during pulmonary vein ablation (PVA). We aimed to determine whether the additional use of a circular mapping catheter (CMC) influences efficacy and outcome of RMN-guided PVA. METHODS: A total of 80 consecutive subjects (65 % male, age 62 ± 9 years) underwent circumferential PVA with a 3D mapping system and an RMN-guided irrigated catheter. Procedural endpoint was complete PV isolation (PVI), total radiofrequency (RF) time >60 min, or procedure duration >5 h. PVI was defined as an entrance and/or exit block, diagnosed with a CMC within the PV ostium or by pacing via the roving RMN-guided catheter (single-catheter technique). Prolonged Holter monitoring after 3 and 6 months was used to detect atrial tachyarrhythmia (AT/AF) recurrences. RESULTS: Complete PVI was achieved in 56 % (45/80) of all subjects (isolated PVs per patient, 3.1 ± 1.2; RF time, 56.3 ± 17.2 min; procedure duration, 3.8 ± 0.8 h). Prospective validation of the single-catheter technique for diagnosing PVI demonstrated high concordance (94 %) with blinded CMC results. CMC use in first-time PVA was associated with similar total RF and procedure times but higher PV isolation rate. Upon multivariate analysis, CMC use, female gender, left PV, smaller PV ostium and repeat PVA predicted PVI during RMN-guided ablation. Persistent AF and mitral regurgitation at baseline and the number of non-isolated PVs predicted AT/AF recurrence during follow-up. CONCLUSIONS: Concomitant CMC use for first-time, RMN-guided PVA is associated with similar procedure duration but higher PV isolation rates as compared to a single-catheter approach. Since the number of isolated PVs predicts freedom from AT/AF, CMC utilization appears advisable for first-time, RMN-guided PVA.


Subject(s)
Atrial Fibrillation/surgery , Catheter Ablation/instrumentation , Magnetics/instrumentation , Pulmonary Veins/surgery , Aged , Atrial Fibrillation/physiopathology , Echocardiography, Transesophageal , Electrocardiography , Electrocardiography, Ambulatory , Electrophysiologic Techniques, Cardiac , Female , Humans , Male , Middle Aged , Prospective Studies , Radio Waves , Retrospective Studies , Risk Factors , Treatment Outcome
6.
Europace ; 14(3): 416-22, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22117037

ABSTRACT

AIMS: The EUTrigTreat clinical study has been designed as a prospective multicentre observational study and aims to (i) risk stratify patients with an implantable cardioverter defibrillator (ICD) for mortality and shock risk using multiple novel and established risk markers, (ii) explore a link between repolarization biomarkers and genetics of ion (Ca(2+), Na(+), K(+)) metabolism, (iii) compare the results of invasive and non-invasive electrophysiological (EP) testing, (iv) assess changes of non-invasive risk stratification tests over time, and (v) associate arrythmogenomic risk through 19 candidate genes. METHODS AND RESULTS: Patients with clinical ICD indication are eligible for the trial. Upon inclusion, patients will undergo non-invasive risk stratification, including beat-to-beat variability of repolarization (BVR), T-wave alternans, T-wave morphology variables, ambient arrhythmias from Holter, heart rate variability, and heart rate turbulence. Non-invasive or invasive programmed electrical stimulation will assess inducibility of ventricular arrhythmias, with the latter including recordings of monophasic action potentials and assessment of restitution properties. Established candidate genes are screened for variants. The primary endpoint is all-cause mortality, while one of the secondary endpoints is ICD shock risk. A mean follow-up of 3.3 years is anticipated. Non-invasive testing will be repeated annually during follow-up. It has been calculated that 700 patients are required to identify risk predictors of the primary endpoint, with a possible increase to 1000 patients based on interim risk analysis. CONCLUSION: The EUTrigTreat clinical study aims to overcome current shortcomings in sudden cardiac death risk stratification and to answer several related research questions. The initial patient recruitment is expected to be completed in July 2012, and follow-up is expected to end in September 2014. Clinicaltrials.gov identifier: NCT01209494.


Subject(s)
Arrhythmias, Cardiac/genetics , Clinical Trials as Topic , Genotype , Multicenter Studies as Topic , Research Design , Arrhythmias, Cardiac/metabolism , Arrhythmias, Cardiac/mortality , Arrhythmias, Cardiac/physiopathology , Calcium/metabolism , Cause of Death , Defibrillators, Implantable , Electrophysiologic Techniques, Cardiac , Female , Heart Rate/physiology , Humans , Male , Potassium/metabolism , Risk , Sodium/metabolism
7.
J Am Coll Cardiol ; 47(3): 644-53, 2006 Feb 07.
Article in English | MEDLINE | ID: mdl-16458150

ABSTRACT

OBJECTIVES: This study was designed to investigate the mutual effects of chronic atrial dilation and electrical remodeling on the characteristics of atrial fibrillation (AF). BACKGROUND: Both electrical remodeling and atrial dilation promote the inducibility and perpetuation of AF. METHODS: In seven goats AF was induced during 48 h by burst pacing, both at baseline and after four weeks of slow idioventricular rhythm (total AV block). Atrial size and refractory period (AERP) were monitored together with the duration and cycle length of AF paroxysms (AFCL). After four weeks of total atrioventricular (AV) block, the conduction in both atria was mapped during AF. Six non-instrumented goats served as controls. RESULTS: At baseline, AF-induced electrical remodeling shortened AERP and AFCL to the same extent (from 185 +/- 9 ms to 149 +/- 14 ms [p < 0.05] and from 154 +/- 11 ms to 121 +/- 5 ms [p < 0.05], respectively). After four weeks of AV block the right atrial diameter had increased by 13.2 +/- 3.0% (p < 0.01). Surprisingly, in dilated atria electrical remodeling still shortened the AERP (from 165 +/- 9 ms to 132 +/- 15 ms [p < 0.05]) but failed to shorten the AFCL (140 +/- 19 ms vs. 139 +/- 11 ms [p = 0.98]). Mapping revealed a higher incidence of intra-atrial conduction delays during AF. Histologic analysis showed no atrial fibrosis but did reveal a positive correlation between the size of atrial myocytes and the incidence of intra-atrial conduction block (r = 0.60, p = 0.03). CONCLUSIONS: In a goat model of chronic atrial dilation, AF-induced electrical remodeling was unchanged. However, AFCL no longer shortened during electrical remodeling. Thus, in dilated atria a wider excitable gap exists during AF, probably caused by intra-atrial conduction defects and a higher contribution of anatomically defined re-entrant circuits.


Subject(s)
Atrial Fibrillation/physiopathology , Heart Atria/physiopathology , Heart Conduction System/physiopathology , Animals , Atrial Fibrillation/etiology , Atrial Fibrillation/pathology , Dilatation, Pathologic , Electrophysiologic Techniques, Cardiac , Female , Goats , Heart Atria/innervation , Heart Atria/pathology , Heart Block/complications , Heart Block/physiopathology , Refractory Period, Electrophysiological
8.
Pacing Clin Electrophysiol ; 26(1P2): 457-60, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12687867

ABSTRACT

The high energy lead impedance is valuable for detecting lead failure in ICDs, but until recently shock delivery was necessary for high energy impedance measurement. This study compared the use of subthreshold test pulses and low energy test shocks to estimate the high energy impedance. Immediately after implantation of Ventak Prizm ICDs in 29 patients, the lead impedance was measured with five subthreshold (0.4 microJ) test pulses, 5 low energy (1.1 J) shocks, and two to three high energy (16 +/- 4.5 J) shocks. The mean impedances measured using high energy shocks, low energy shocks, and subthreshold pulses were 42.0 +/- 7.3 omega, 46.5 +/- 8.1 omega, and 42.4 +/- 7.1 omega, respectively. The impedances measured using high and low energy shocks differed significantly (P < 0.0001), while those obtained by high energy shocks and low energy pulses did not (P = 0.63). According to the Pearson correlation coefficient, the impedance measurements with subthreshold pulses and low energy shocks were both closely correlated (P < 0.0001) with impedance values determined with high energy shocks. However, while the impedance values tended to be higher when measured with low energy shocks, the concordance correlation coefficient (c) was higher for subthreshold test pulse versus high energy shock (c = 0.92) than for low versus high energy shock (c = 0.73). Furthermore, the intraindividual variability of impedance measurements was lower with subthreshold pulse measurements than with low energy shocks. Compared with low energy shocks, impedance measurement with subthreshold pulses has higher reproducibility and a higher correlation with the impedance obtained by high energy shock delivery. Safe and painless high energy impedance estimation with subthreshold pulses might, therefore, help to detect ICD lead failure during routine follow-up.


Subject(s)
Defibrillators, Implantable , Aged , Electric Impedance , Electrophysiologic Techniques, Cardiac , Equipment Failure , Female , Humans , Male , Prospective Studies , Reproducibility of Results
SELECTION OF CITATIONS
SEARCH DETAIL